Bing

SEARCH HISTORY

Ziopharm Oncology Inc (ZIOP): ZIOP stock is up 5.1% today. Vertex Pharmaceuticals Inc (VRTX): VRTX stock is up 4.1% today. Owens & Minor (OMI): OMI stock is up 4.0% today on 5 times normal volume. Allergan Plc (AGN): AGN stock is up 3.8% …
Investor Place · 7/28/2015
Healthcare Stocks
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Vertex Pharmaceuticals ( VRTX) as a post-market ...
The Street · 7/29/2015
Vertex Pharmaceuticals
Look at a long-term chart for Vertex Pharmaceuticals (NASDAQ: VRTX) stock, and you'll see one heck of a wild ride. Investors who got in at the initial public offering are up more than 20-fold, crushing the market's return …
The Motley Fool · 17 hours ago
Vertex
More from Bing News
Vertex Pharmaceuticals (NASDAQ:VRTX) rose 6.3% during trading on Thursday after the company announced better than expected quarterly earnings, Analyst Ratings Network.com reports. The company traded as high as $133.69 and last traded at $133.
wkrb13.com · 1 day ago
Vertex Pharmaceuticals (NASDAQ:VRTX)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a report issued on Thursday, Analyst Ratings Network.com reports. In other Vertex Pharmaceuticals news, Director …
Ticker Report · 1 day ago
In the top ten holdings, Mylan (MYLN) has the lowest PVB of 3.69 compared to the industry average of 11.62, indicating a case of possible undervaluation of the stock. On the other hand, VRTX has the highest PVB ratio …
Yahoo Finance · 1 day ago
One of the S&P 500’s big winners for Thursday July 30 was Vertex Pharmaceuticals Incorporated (VRTX) as the company’s stock climbed 7.83% to $135.46 on volume of 3.1 million shares. The stock opened at $126.09 and saw an intraday low of $121.
Equities · 7/30/2015
Vertex Pharmaceuticals Incorpo…
CHICAGO, July 31, 2015 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LINE, BAC, NFLX, GE and VRTX. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by …
Market Watch · 23 hours ago
JMP Securities reiterated their buy rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX) in a research note released on Thursday, Marketbeat.com reports. They currently have a $148.00 price target on the pharmaceutical company’s stock. Vertex ...
Mideast Times · 1 day ago
Biotech company, Vertex Pharmaceuticals (VRTX - Analyst Report), will be reporting second quarter 2015 earnings results on Jul 29, after the market closes. Vertex’s track record has not been that great with the company posting a wider-than-expected …
ZACKS · 7/28/2015
Vertex

Vertex Pharmaceuticals

Company
Vertex Pharmaceuticals is an American Pharmaceutical company based in Boston, Massachusetts. Vertex was founded in 1989 by Joshu…
Vertex Pharmaceuticals is an American Pharmaceutical company based in Boston, Massachusetts. Vertex was founded in 1989 by Joshua Boger and Kevin J. Kinsella. Vertex was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Data from: Wikipedia · Freebase